Phathom Pharmaceuticals Stock Doubles After FDA Grants Full 10-Year Exclusivity For Voquezna

How did Musk-Trump feud impact Tesla stock? What’s behind the S&P 500 hitting 6,000? Why is China easing rare earth export controls? How will US-China trade talks in London affect markets? What caused Lululemon’s stock to crash? Why are companies scaling back Pride Month celebrations? What’s the effect of tariffs on US small businesses?

Phathom Pharmaceuticals Stock Doubles After FDA Grants Full 10-Year Exclusivity For Voquezna

benzinga.com/trading-ideas/movers/25/06/45822341/phathom-pharmaceuticals-stock-doubles-after-fda-grants-full-10-year-exclusivity-for-voquezna

Phathom Pharmaceuticals Inc. (NASDAQ:PHAT) shares are trading higher Friday after the company announced a major regulatory win.
What To Know: The FDA has granted 10-year new chemical entity exclusivity for its drug Voquezna, extending full market protection through May 3 2032. The FDA…

This story appeared on benzinga.com, 2025-06-06 19:24:24.